EQUIFAX ($EFX) posted quarterly earnings results for Q1 2026 on Tuesday, April 21st. The company reported earnings of $1.86 per share, beating estimates of $1.72 by $0.14. The company also reported revenue of $1,648,900,000, beating estimates of $1,631,938,810 by $16,961,190.
You can see Quiver Quantitative's $EFX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
EQUIFAX Insider Trading Activity
EQUIFAX insiders have traded $EFX stock on the open market 32 times in the past 6 months. Of those trades, 1 have been purchases and 31 have been sales.
Here’s a breakdown of recent trading of $EFX stock by insiders over the last 6 months:
- MARK W BEGOR (CEO) has made 0 purchases and 25 sales selling 87,136 shares for an estimated $19,033,631.
- JAMIL FARSHCHI (EVP, Chief Technology Officer) has made 0 purchases and 3 sales selling 12,305 shares for an estimated $2,626,595.
- JOHN W JR GAMBLE (EVP, CFO & COO) has made 0 purchases and 2 sales selling 7,000 shares for an estimated $1,401,665.
- CHAD M BORTON (EVP, Pres Workforce Solutions) sold 2,535 shares for an estimated $485,452
- CECILIA MAO (EVP, Chief Product Officer) purchased 2,400 shares for an estimated $464,928
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
EQUIFAX Hedge Fund Activity
We have seen 407 institutional investors add shares of EQUIFAX stock to their portfolio, and 413 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS removed 3,995,916 shares (-38.3%) from their portfolio in Q4 2025, for an estimated $867,033,853
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,145,659 shares (-74.6%) from their portfolio in Q4 2025, for an estimated $682,545,089
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,741,584 shares (-29.2%) from their portfolio in Q4 2025, for an estimated $377,888,896
- HARRIS ASSOCIATES L P added 1,723,439 shares (+29.5%) to their portfolio in Q4 2025, for an estimated $373,951,794
- PARNASSUS INVESTMENTS, LLC removed 1,654,544 shares (-94.4%) from their portfolio in Q4 2025, for an estimated $359,002,957
- FMR LLC removed 1,579,807 shares (-87.0%) from their portfolio in Q4 2025, for an estimated $342,786,522
- GENERATION INVESTMENT MANAGEMENT LLP removed 1,164,793 shares (-42.6%) from their portfolio in Q4 2025, for an estimated $252,736,785
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
EQUIFAX Government Contracts
We have seen $77,107,993 of award payments to $EFX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- TASK ORDER FOR MATCHED HITS FOR THE PAYROLL INFORMATION EXCHANGE (PIE) FROM 4/1/2025 THROUGH 3/31/2026: $49,800,000
- CALL ORDER AGAINST BPA 28321322A0004007 FOR THE ONLINE WAGE VERIFICATION SERVICES. PERIOD OF PERFORMANCE 09...: $11,972,785
- TO FUND OPTION PERIOD 3 FOR BPA CALL AGAINST SET UP 28321322A0004007 FOR THE ONLINE WAGE VERIFICATION SERVI...: $6,993,423
- EMPLOYMENT VERIFICATION SERVICES: $2,369,815
- EMPLOYMENT VERIFICATION (EV) AND UNEMPLOYMENT CLAIMS (UC) SERVICES FOR THE HUMAN RESOURCES DIRECTORATE (HRD...: $258,321
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
EQUIFAX Congressional Stock Trading
Members of Congress have traded $EFX stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $EFX stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 03/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
EQUIFAX Analyst Ratings
Wall Street analysts have issued reports on $EFX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 11/07/2025
To track analyst ratings and price targets for EQUIFAX, check out Quiver Quantitative's $EFX forecast page.
EQUIFAX Price Targets
Multiple analysts have issued price targets for $EFX recently. We have seen 13 analysts offer price targets for $EFX in the last 6 months, with a median target of $230.0.
Here are some recent targets:
- Sean Kennedy from Mizuho set a target price of $222.0 on 04/16/2026
- Kevin Mcveigh from UBS set a target price of $220.0 on 04/13/2026
- George Tong from Goldman Sachs set a target price of $208.0 on 02/09/2026
- Jason Haas from Wells Fargo set a target price of $240.0 on 02/05/2026
- Toni Kaplan from Morgan Stanley set a target price of $244.0 on 02/05/2026
- Kyle Peterson from Needham set a target price of $265.0 on 02/05/2026
- Manav Patnaik from Barclays set a target price of $215.0 on 02/05/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
